Skip to main content
. 2020 May 15;11:485. doi: 10.3389/fgene.2020.00485

FIGURE 1.

FIGURE 1

The expression of circRNA_103809 in breast cancer patients and clinicopathological parameters of patients. (A) CircRNA_103809 is significantly downregulated (69.2%, 20/65) in patients with breast cancer. (B) The expression level of circRNA_103809 is significantly lower in breast cancer tissues than in normal tissues. (C) The correlation between the expression of circRNA_103809 and TNM stages. (D) The relationship between circRNA_103809 expression and tumor metastasis. (E) The relationship between circRNA_103809 expression and Her-2 positive expression. (F) The correlation between the expression of circRNA_103809 and overall survival rates of patients with breast cancer. All experiments were repeated at least three times, *P < 0.05, **P < 0.01, ***P < 0.001.